EUR 306.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 854.98 Thousand EUR | -11.33% |
2022 | 8.65 Million EUR | 43.86% |
2021 | 6.01 Million EUR | 619.31% |
2020 | 837.74 Thousand EUR | 218.96% |
2019 | 263.27 Thousand EUR | 302.85% |
2018 | -129.24 Thousand EUR | 73.42% |
2017 | -486.23 Thousand EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 3.52 Million EUR | 0.0% |
2023 FY | - EUR | -11.33% |
2023 Q2 | 2.88 Million EUR | 0.0% |
2023 Q4 | 4.79 Million EUR | 0.0% |
2022 Q2 | 4.13 Million EUR | 0.0% |
2022 FY | - EUR | 43.86% |
2022 Q4 | 4.52 Million EUR | 0.0% |
2021 FY | - EUR | 619.31% |
2021 Q4 | 3.73 Million EUR | 0.0% |
2021 Q2 | 2.27 Million EUR | 0.0% |
2020 FY | - EUR | 218.96% |
2020 Q4 | 823.05 Thousand EUR | 0.0% |
2020 Q2 | 14.69 Thousand EUR | 0.0% |
2019 Q4 | 232.25 Thousand EUR | 0.0% |
2019 Q2 | 29.92 Thousand EUR | 0.0% |
2019 FY | - EUR | 302.85% |
2018 Q4 | 167.82 Thousand EUR | 0.0% |
2018 FY | - EUR | 73.42% |
2018 Q3 | 167.82 Thousand EUR | 172.2% |
2018 Q1 | -232.44 Thousand EUR | -623.15% |
2018 Q2 | -232.44 Thousand EUR | -0.0% |
2017 Q4 | -32.14 Thousand EUR | 0.0% |
2017 Q1 | -121.33 Thousand EUR | 0.0% |
2017 FY | - EUR | 0.0% |
2017 Q2 | -121.33 Thousand EUR | 0.0% |
2016 Q4 | -121.33 Thousand EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 2.93 Billion EUR | 99.971% |
Fresenius SE & Co. KGaA | 2.73 Billion EUR | 99.969% |
M1 Kliniken AG | 21.79 Million EUR | 96.077% |
Maternus-Kliniken Aktiengesellschaft | 4.71 Million EUR | 81.867% |
MEDICLIN Aktiengesellschaft | 101.26 Million EUR | 99.156% |
RHÖN-KLINIKUM Aktiengesellschaft | 116.58 Million EUR | 99.267% |
VITA 34 AG | 5.8 Million EUR | 85.274% |